"Pulmonary hypertension" of the gastrointestinal tract in patients with systemic sclerosis: Thoughts on a not (yet) existing disease entity;"Pulmonale hypertonie" des gastrointestinaltraktes bei patienten mit systemischer sklerose: Überlegungen zu einem (noch) nicht existierenden krankheitsbild

Deutsche Medizinische Wochenschrift

Volumn 133, Issue 40 SUPPL. 6, 2008, Pages

  Müller Ladner, Ulf ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Endothelin 1 receptor antagonists; Gastrointestinal motility; Gastrointestinal vascular changes; Pulmonary hypertension; Systemic sclerosis

Indexed keywords

CELL PROLIFERATION; CONFERENCE PAPER; ENDOTHELIAL DYSFUNCTION; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HISTOPATHOLOGY; HUMAN; INTESTINAL FIBROSIS; LUNG PARENCHYMA; MESENTERIC ARTERY; PULMONARY HYPERTENSION; SYSTEMIC SCLEROSIS; VASOSPASM;

FIBROSIS; GASTRIC MUCOSA; GASTROINTESTINAL DISEASES; GASTROINTESTINAL MOTILITY; GASTROINTESTINAL TRACT; HUMANS; HYPERTENSION, PULMONARY; LUNG; MESENTERIC ARTERIES; SCLERODERMA, SYSTEMIC; TELANGIECTASIS;

EID: 53849147615     PISSN: 00120472     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-0028-1091239     Document Type: Conference Paper

References (10)

1. Elkayam O, Oumanski M, Yaron M, Caspi D. Watermelon stomach following and preceding systemic sclerosis. Semin Arthritis Rheum 2000; 30: 127-31
2. Hunzelmann N, Genth E, Krieg T et al. The registry of the German Network for Systemic Scleroderma: frequency of disease subsets and patterns of organ involvement. Rheumatology (Oxford), 2008
3. Ibba-Manneschi L, Del Rosso A, Pacini S, Tani A, Bechi P, Matucci Cerinic M. Ultrastructural study of the muscle coat of the gastric wall in a case of systemic sclerosis. Ann Rheum Dis 2002; 61: 754-6
4. Manetti M, Neumann E, Milia AF et al. Severe fibrosis and increased expression of fibrogenic cytokines in the gastric wall of systemic sclerosis patients. Arthritis Rheum 2007; 56: 3442-7
5. Manetti M, Neumann E, Müller A et al. Endothelial/lymphocyte activation leads to a prominent CD4+ T cell infiltration in the gastric mucosa of systemic sclerosis patients. Arthritis Rheum, 2008 (im Druck)
6. Roberts CG, Hummers LK, Ravich WJ, Wigley FM, Hutchins GM. A case-control study of the pathology of oesophageal disease in systemic sclerosis (scleroderma). Gut 2006; 55: 1697-703
7. Russell ML, Friesen D, Henderson RD, Hanna WM. Ultrastructure of the esophagus in scleroderma. Arthritis Rheum 1982; 25: 1117-23
8. Saar P, Müller A, Noethe M et al. Evaluation des Pilotfragebogens zu Art und Ausmaß der gastrointestinalen Beteiligung bei Patienten mit systemischer Sklerose (limitiert/diffus) im Rahmen des Deutschen Netzwerks für systemische Sklerodermie. 7 Rheumatol 2006; Suppl. 1: S61
9. Trompeter M, Brazda T, Remy CT, Vestring T, Reimer P. Non-occlusive mesenteric ischemia: etiology, diagnosis, and interventional therapy. Eur Radiol 2002; 12: 1179-87
10. Walker UA, Tyndall A, Czirjak L et al. Clinical risk assessment of organ manifestations in systemic sclerosis: a report from the EULAR Scleroderma Trials And Research group database. Ann Rheum Dis 2007; 66: 754-63